Skip to content

Curo B3

by Kpi Healthcare, Inc.

Curo B3 is a medical device (FDA Class II; FDA product code DXN, System, Measurement, Blood-Pressure, Non-Invasive) made by Kpi Healthcare, Inc., listed in FDA GUDID since 26 Apr 2019 (UDI-DI 00860394001232), registry data as of 22 Oct 2026.

Listed FDA GUDID listing, no authorization on record

Valid until

Not applicable

Database listing, no authorization

FDA recalls

Not checked

No FDA submission to match recalls against

Documents

None

No authorization documents

Trust

Unverified

Source GUDID, synced 22 Oct 2026.

Regulatory status

as of registry sync 22 Oct 2026

RegionAuthorizationNumberDateStatus
United StatesGUDID listing Number00860394001232 UDI-DI Date26 Apr 2019ListedStatusListed GUDID: in commercial distribution

Official records

From the FDA record

Device description
CURO B3 Blood Pressure Monitor
MRI safety
Labeling does not contain MRI Safety Information
Natural rubber latex
No latex statement on the label
Sterility
Supplied non-sterile

From the GUDID record (AccessGUDID), as read on 22 Oct 2026, as the labeller entered it.

Coverage

1 jurisdiction

United States of America
  • Active
  • Expiring
  • Withdrawn
  • Listed
  • Not covered

United States — GUDID listing Listed

Specification

GUDID

Generic name
Ambulatory insulin infusion pump/interstitial glucose monitoring system
Model / reference
CURO B3
Primary DI / UDI-DI
00860394001232
FDA product code
DXN
GMDN term
Ambulatory insulin infusion pump/interstitial glucose monitoring system
Device class
Class II
Regulation number
870.1130
GUDID distribution status
In Commercial Distribution

Similar devices

Other devices filed under FDA product code DXN (System, Measurement, Blood-Pressure, Non-Invasive).

Other devices from Kpi Healthcare, Inc.

  • CURO A1c

    Class II
  • Curo L5

    Class I
  • CURO L5 Total Cholesterol Strips

    Class II
  • CURO G6 Glucose Meter

    Class II

See all devices from Kpi Healthcare, Inc. →

Properties

  • Lot / batch number
Other properties (14, all answered No)